Inventor

Thomas H. King

Inventor

Denver, CO, US

Overview

1999–2020

Patent span

Chemistry

Primary field (CPC C)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes25%

C12NMicroorganisms or enzymes24%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%

C07KPeptides22%

B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%

C40BCombinatorial chemistry2%

G01NInvestigating or analysing materials by determining their chemical or physical properties1%

PatentTitleYear

10,849,971Compositions and methods for the treatment or prevention of human immunodeficiency virus infection2020 10,799,567Yeast-based immunotherapy and type I interferon sensitivity2020 10,722,567Compositions and methods for the treatment or prevention of tuberculosis2020 10,441,650Compositions and methods for the treatment or prevention of hepatitis B virus infection2019 10,265,393Compositions and methods for the treatment or prevention of human immunodeficiency virus infection2019 10,226,522Compositions and methods for the treatment or prevention of tuberculosis2019 9,987,352Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection2018 9,943,591Compositions and methods for the treatment or prevention of hepatitis B virus infection2018 9,782,473'Compositions and methods for the treatment or prevention of human immunodeficiency virus infection'2017 9,579,377'Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection'2017 9,428,556'Compositions and methods for the treatment or prevention of hepatitis B virus infection'2016 9,290,547'Yeast-based therapeutic for chronic hepatitis B infection'2016 9,254,320'Compositions and methods for the treatment or prevention of human adenovirus-36 infection'2016 8,961,988'Compositions and methods for the treatment or prevention of hepatitis B virus infection'2015 8,877,205'Yeast-based therapeutic for chronic hepatitis B infection'2014 8,821,892'Yeast-based therapeutic for chronic hepatitis C infection'2014 8,722,054'Compositions and methods for the treatment or prevention of hepatitis B virus infection'2014 8,388,980'Yeast-based therapeutic for chronic hepatitis C infection'2013 8,007,816'Yeast-based therapeutic for chronic hepatitis C infection'2011 7,736,642'Yeast-based vaccine for inducing an immune response'2010 7,632,511'Yeast-based therapeutic for chronic hepatitis C infection'2009 7,625,569'Yeast-based therapeutic for chronic hepatitis C infection'2009 7,439,042'Yeast-based therapeutic for chronic hepatitis C infection'2008 6,168,922'Methods and devices for collecting and storing clinical samples for genetic analysis'2001 5,939,259'Methods and devices for collecting and storing clinical samples for genetic analysis'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2001Patents assigned to SCHLEICHER & SCHUELL INC (2)· patent assignee history

1999–2001Based in Brattleboro, VT, US· patent location history

2008–2020Patents assigned to GLOBEIMMUNE INC (23)· patent assignee history

2008–2020Based in Denver, CO, US· patent location history

2013–2017Patents assigned to KING THOMAS H (3)· patent assignee history

2014–2017Patents assigned to APELIAN DAVID (3)· patent assignee history

2014–2016Patents assigned to COESHOTT CLAIRE (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
GLOBEIMMUNE INC	23	2008–2020
APELIAN DAVID	3	2014–2017
KING THOMAS Hself	3	2013–2017
COESHOTT CLAIRE	2	2014–2016
SCHLEICHER & SCHUELL INC	2	1999–2001

Locations

Location	Patents	Span
Denver, CO, US	23	2008–2020
Brattleboro, VT, US	2	1999–2001